Stockreport

Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here? [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF In the week ended Dec. 19, that message was clear. ARK Investment Management leaned harder into AI-led biotechnology and crypto, while paring back exposure to consumer t [Read more]